Ekso Bionics Inc.

NASDAQ: EKSO · Real-Time Price · USD
3.14
-0.06 (-2.03%)
At close: Aug 14, 2025, 3:59 PM
3.19
1.59%
Pre-market: Aug 15, 2025, 06:19 AM EDT

Ekso Bionics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
17.93M 18.28M 12.91M 11.25M
Cost of Revenue
8.41M 9.2M 6.7M 4.5M
Gross Profit
9.51M 9.08M 6.21M 6.75M
Operating Income
-10.46M -15.11M -15.56M -13.83M
Interest Income
n/a n/a n/a n/a
Pretax Income
-11.33M -15.2M -15.08M -9.76M
Net Income
-11.33M -15.2M -14.6M -8.43M
Selling & General & Admin
16.1M 19.17M 18.14M 17.83M
Research & Development
3.87M 5.03M 3.63M 2.75M
Other Expenses
n/a n/a -30K n/a
Operating Expenses
19.97M 24.19M 21.77M 20.58M
Interest Expense
269K 302K 156K 113K
Selling & Marketing Expenses
7.31M 8.47M 7.16M 7.3M
Cost & Expenses
28.39M 33.39M 28.47M 25.07M
Income Tax Expense
n/a n/a -476K -1.33M
Shares Outstanding (Basic)
20.16M 13.87M 12.96M 12.19M
Shares Outstanding (Diluted)
20.16M 13.87M 12.96M 12.27M
EPS (Basic)
-0.56 -1.1 -1.13 -0.69
EPS (Diluted)
-0.56 -1.1 -1.13 -0.69
EBITDA
-9.45M -13.2M -14.04M -9.09M
EBIT
-11.06M -14.9M -14.92M -9.65M
Depreciation & Amortization
1.61M 1.7M 887K 561K